Grail and quest diagnostics announce collaboration to support galleri, first-of-kind multi-cancer early detection blood test

Menlo park, calif.--(business wire)--grail, inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced an agreement with quest diagnostics (nyse: dgx), the leading provider of diagnostic information services, to provide phlebotomy services to support galleri™, grail's multi-cancer early detection blood test. quest diagnostics maintains approximately 2,200 patient service centers and, through its examone business, 5,000 mobile phlebotomists with exp
DGX Ratings Summary
DGX Quant Ranking